Open AccessExamination of the effect of COVID‐19 on sexual dysfunction in women
Author(s) -
Kaya Yeliz,
Kaya Coşkun,
Tahta Tuğba,
Kartal Tuğba,
Tokgöz Vehbi Yavuz
Publication year - 2021
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.13923
Subject(s) - medicine , covid-19 , coronavirus infections , betacoronavirus , virology , disease , outbreak , infectious disease (medical specialty)
Objective To investigate the effect of COVID‐19 on sexual dysfunction in women. Material and Methods The women diagnosed with COVID‐19 and hospitalised at a tertiary hospital were included. They completed the Introductory Data Form, the Female Sexual Function Index‐(FSFI) and the Short Form‐36 Quality of Life Scale (SF‐36). Results Fifteen women between the ages of 19‐49 who completed the treatment protocol, discharged at least 14 days before and who had not been diagnosed as sexual dysfunction; sexually active earlier were included in the study. It was detected that weekly sexual intercourse before and after COVID‐19 significantly differed ( P = .047). The frequency of relationships decreased statistically after COVID‐19. The mean value of the FSFI satisfaction score differs from COVID‐19 before and after diagnosis ( P = .012). The mean satisfaction score before COVID‐19 was 3.47, and after COVID‐19 was 2.93. The score of the subgroups of FSFI did not differ from COVID‐19 before and after diagnosis ( P > .050). The median value of SF‐36 pain differs from COVID‐19 before and after diagnosis ( P = .008). Conclusion It was concluded that the frequency of sexual intercourse and sexual satisfaction in women decreased after COVID‐19 disease, and the quality of life scores did not change in a statistically significant way.